![](/img/cover-not-exists.png)
Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer
Dellis, Athanasios, Papatsoris, AthanasiosLanguage:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1586/14737167.2016.1123624
Date:
November, 2015
File:
PDF, 680 KB
english, 2015